Schrödinger, Inc. (NASDAQ:SDGR) Q2 2020 Earnings Conference Call August 10, 2020 8:30 AM ET Company Participants Ramy Farid - President and CEO Karen Akinsanya - EVP, Chief Biomedical Scientist, Head of Discovery R&D Joel Lebowitz - EVP and CFO Conference Call Participants David Lebowitz - Morgan Stanley Do Kim - BMO Capital Markets Mike Ryskin - Bank of America Operator Good morning and welcome to the Schrödinger Second Quarter 2020 Earnings Conference Call. At this time, all participant lines are in a lis ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-39206 Schrodinger, Inc. (Exact Name of Registrant as Specified in its Charter) | Delaware | | | 95-4284541 | | | --- | --- | --- | ...

SCHRÖDINGER. Transforming Discovery of Therapeutics and Materials Cautionary Note and Disclaimer This presentation contains certain "forward-looking statements" within the meaning of the U.S. Private Securities Litigation Reform Act of 1995 that involve substantial risks and uncertainties. All statements, other than statements of historical fact, contained in this presentation, including, without limitation, statements regarding the potential advantages of our physics-based computational platform, our strat ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-39206 Schrodinger, Inc. (Exact Name of Registrant as Specified in its Charter) | Delaware | 95-4284541 | | --- | --- | | (State o ...

Schrödinger, Inc. (NASDAQ:SDGR) Q1 2020 Earnings Conference Call May 13, 2020 8:30 AM ET Company Participants Ramy Farid - President and CEO, Board Member Karen Akinsanya - Executive Vice President, Chief Biomedical Scientist, Head of Discovery R&D Joel Lebowitz - Executive Vice President, Chief Financial Officer Conference Call Participants Michael Yee - Jefferies Operator Good Morning, and welcome to the Schrödinger First Quarter 2020 Earnings Conference Call. At this time, all participants are in a list ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2019 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commission File Number 001-39206 Schrödinger, Inc. (Exact name of Registrant as specified in its Charter) Delaware 95-4284541 (State or other jurisdiction of in ...